These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6379956)

  • 1. Prostacyclin synthetase activity in diabetic human venous tissue.
    Saroyan RM; Kerstein MD; Kadowitz PJ; Hyman AL; McNamara DB
    Surgery; 1984 Aug; 96(2):179-83. PubMed ID: 6379956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin synthetase activity in human diabetic and nondiabetic vascular tissue.
    McNamara DB; Donath GR; Kadowitz PJ; Hyman AL; Rush DS; Kerstein MD
    J Vasc Surg; 1986 Jul; 4(1):63-7. PubMed ID: 3522943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of prostaglandins in human saphenous vein.
    Kerstein MD; Saroyan M; McMullen-Laird M; Hyman AL; Kadowitz P; McNamara DB
    J Surg Res; 1983 Aug; 35(2):91-100. PubMed ID: 6350708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased prostacyclin and thromboxane A2 formation in human varicose veins.
    Haynes DF; Kerstein MD; Roberts MP; Bell WH; Rush DS; Kadowitz PJ; McNamara DB
    J Surg Res; 1990 Sep; 49(3):228-32. PubMed ID: 2118584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostacyclin production in internal mammary ano radial arteries and saphenous veins of diabetic and non diabetic subjects].
    Guivernau M; Berr M
    Rev Med Chil; 2008 Jul; 136(7):823-30. PubMed ID: 18949156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study.
    Costantini V; Talpacci A; Bastiano ML; Boschetti E; Cipolloni S; Bisacci R; Nenci GG
    Biomed Biochim Acta; 1990; 49(4):263-71. PubMed ID: 2119575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversions of prostaglandin endoperoxides by prostacyclin synthase from pig aorta.
    Wlodawer P; Hammarström S
    Prostaglandins; 1980 Jun; 19(6):969-76. PubMed ID: 6992239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of the PGI2 producing enzyme system in the pathogenesis of pregnancy-induced hypertension].
    Seki H; Mitsuhashi N; Mizuno M; Satoh K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1189-94. PubMed ID: 2120373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.
    Salzman PM; Salmon JA; Moncada S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):240-7. PubMed ID: 7005425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin I2 (prostacyclin) formation in lung tissues of Swiss mice.
    Hokama Y; Matsuo M; Seto DS
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):145-8. PubMed ID: 6359307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prostacyclin synthetase activity of fetal rat aorta. Progressive increase after birth.
    Deckmyn H; Font L; Van Hemelen C; Carreras LO; Defreyn G; Vermylen J
    Life Sci; 1983 Oct; 33(15):1491-7. PubMed ID: 6413801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the activity of the PGI2 producing enzyme system derived from maternal and fetal vessels of toxemia of pregnancies].
    Seki H; Mizuno M; Satoh K; Nakabayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):905-10. PubMed ID: 3112293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased prostacyclin production in the infant of the diabetic mother.
    Stuart MJ; Sunderji SG; Allen JB
    J Lab Clin Med; 1981 Sep; 98(3):412-16. PubMed ID: 6790644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human placental anti-aggregating factor is neither prostacyclin, nor a prostacyclin metabolite.
    Dembélé-Duchesne MJ; Thaler-Dao H; Chavis C; Crastes de Paulet A
    Prostaglandins; 1982 Nov; 24(5):701-14. PubMed ID: 6298904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.
    Marnett LJ; Siedlik PH; Ochs RC; Pagels WR; Das M; Honn KV; Warnock RH; Tainer BE; Eling TE
    Mol Pharmacol; 1984 Sep; 26(2):328-35. PubMed ID: 6434940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin biosynthetic activities of isolated fetal lamb ductus arteriosus, other blood vessels, and lung tissue.
    Skidgel RA; Friedman WF; Printz MP
    Pediatr Res; 1984 Jan; 18(1):12-8. PubMed ID: 6583652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of a platelet component to endothelial prostacyclin production despite inhibition of platelet cyclooxygenase activity.
    Czervionke RL; Hoak JC; Haycraft DL; Fry GL; Mann KG
    Trans Assoc Am Physicians; 1982; 95():272-9. PubMed ID: 6820742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of prostacyclin synthase using [5,6-3H]PGH2.
    Tai HH; Sih CJ
    Methods Enzymol; 1982; 86():99-105. PubMed ID: 6813652
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin production in vascular endothelium of patients with Blackfoot disease.
    Mak OT
    Adv Exp Med Biol; 1988; 242():119-25. PubMed ID: 3072861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.